学术探索
学术期刊
新闻热点
数据分析
智能评审

Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, part 2

被引：22
作者：
Armstrong, PW
Collen, D
机构：
[1] Univ Alberta, Edmonton, AB T6G 2H7, Canada
[2] Katholieke Univ Leuven, Louvain, Belgium
来源：
CIRCULATION | 2001年 / 103卷 / 24期
关键词：
fibrinolysis; myocardial infarction; drugs;
D O I：
10.1161/01.CIR.103.24.2987
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2987 / 2992
页数：6
相关论文
共 61 条
  • [1] Anderson JL, 1997, AM J CARDIOL, V80, P1588
  • [2] [Anonymous], 1988, LANCET, V2, P349
  • [3] Abciximab facilitates the rate and extent of thrombolysis - Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
    Antman, EM
    Giugliano, RP
    Gibson, CM
    McCabe, CH
    Coussement, P
    Kleiman, NS
    Vahanian, A
    Adgey, AAJ
    Menown, I
    Rupprecht, HJ
    Van der Wieken, R
    Ducas, J
    Scherer, J
    Anderson, K
    Van de Werf, F
    Braunwald, E
    [J]. CIRCULATION, 1999, 99 (21) : 2720 - 2732
  • [4] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [5] Bolus fibrinolysis - Risk, benefit, and opportunities
    Armstrong, PW
    Granger, C
    Van de Werf, F
    [J]. CIRCULATION, 2001, 103 (08) : 1171 - 1173
  • [6] Test of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) for prehospital use
    Aufderheide, TP
    Rowlandson, I
    Lawrence, SW
    Kuhn, EM
    Selker, HP
    [J]. ANNALS OF EMERGENCY MEDICINE, 1996, 27 (02) : 193 - 198
  • [7] REPEAT INFUSIONS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION AND EARLY RECURRENT MYOCARDIAL-ISCHEMIA
    BARBASH, GI
    HOD, H
    ROTH, A
    FAIBEL, HE
    MANDEL, Y
    MILLER, HI
    RATH, S
    ZAHAV, YH
    RABINOWITZ, B
    SELIGSOHN, U
    PELLED, B
    SCHLESINGER, Z
    MOTRO, M
    LANIADO, S
    KAPLINSKY, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (04) : 779 - 783
  • [8] Use of reperfusion therapy for acute myocardial infarction in the United States - Data from the National Registry of Myocardial Infarction 2
    Barron, HV
    Bowlby, LJ
    Breen, T
    Rogers, WJ
    Canto, JG
    Zhang, YA
    Tiefenbrunn, AJ
    Weaver, WD
    [J]. CIRCULATION, 1998, 97 (12) : 1150 - 1156
  • [9] Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists - Observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study
    Becker, RC
    Hochman, JS
    Cannon, CP
    Spencer, FA
    Ball, SP
    Rizzo, MJ
    Antman, EM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (02) : 479 - 487
  • [10] THROMBOLYTIC RETREATMENT WITH TISSUE-PLASMINOGEN ACTIVATOR FOR THREATENED REINFARCTION AND THROMBOTIC CORONARY REOCCLUSION
    BECKER, RC
    [J]. CLINICAL CARDIOLOGY, 1994, 17 (01) : 3 - 13
1234567